DAIICHI SANKYO CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,010 JPY | +5.12% |
|
+8.07% | +29.39% |
| Apr. 25 | Scholz pledges further support for the pharmaceutical industry | DP |
| Apr. 25 | Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024 | MT |
ETFs positioned on Daiichi Sankyo Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 25.16% | 15 M€ | +7.34% | ||
| 4.18% | 251 M€ | +13.17% | ||
| 3.32% | 174 M€ | -.--% | - | |
| 3.32% | 51 M€ | -.--% | - | |
| 3.24% | 15 M€ | +14.10% | ||
| 2.78% | 81 M€ | +14.05% | ||
| 2.69% | 57 M€ | +19.27% | ||
| 2.19% | 14 M€ | +15.63% | ||
| 2.13% | 73 M€ | +11.61% | ||
| 1.96% | 10,207 M€ | +14.32% | ||
| 1.95% | 5,115 M€ | +13.58% | ||
| 1.71% | 26 M€ | +20.62% | ||
| 1.68% | 16,729 M€ | +13.38% | - | |
| 1.64% | 31,732 M€ | +14.31% | - | |
| 1.63% | 1,198 M€ | +13.48% | - | |
| 1.42% | 66,066 M€ | +14.68% | - | |
| 1.42% | 144,586 M€ | +14.49% | ||
| 1.42% | 20,721 M€ | +13.52% | - | |
| 1.35% | 18 M€ | +16.15% | - | |
| 1.29% | 4 M€ | +13.95% | ||
| 1.08% | 60 M€ | +14.42% | ||
| 0.99% | 67,864 M€ | +14.28% | ||
| 0.69% | 4 M€ | -.--% | - | |
| 0.68% | 717 M€ | +6.20% | ||
| 0.44% | 26 M€ | +2.00% | - | |
| 0.30% | 10 M€ | -3.35% | - | |
| 0.30% | 36 M€ | +1.20% | - | |
| 0.25% | 7 M€ | +1.95% | - | |
| 0.23% | 276 M€ | +11.40% | - |
Daiichi Sankyo Company specializes in developing, manufacturing and marketing pharmaceutical products. Net sales break down by activity as follows:
- sale of medicines (99.8%): prescription medicines (92.8% of net sales) and OTC medicines (7.2%) primarily for the treatment of thrombotic disorders, tumors, diabetes and rheumatoid arthritis;
- other (0.2%): primarily real estate activities.
Net sales are distributed geographically as follows: Japan (64.1%), North America (17.2%), Europe (9.7%) and other (9%).
Sector
Pharmaceuticals
Calendar
2024-07-30
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,010
JPY
Average target price
5,673
JPY
Spread / Average Target
+13.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.39% | 61.03B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4568 Stock
- Funds and ETFs Daiichi Sankyo Co., Ltd.
